» Articles » PMID: 36206914

Inflammation and Fibrosis Characterize Different Stages of Myocardial Remodeling in Patients After Stereotactic Body Radiotherapy of Ventricular Myocardium for Recurrent Ventricular Tachycardia

Abstract

We performed a histological and immunohistochemical analysis of myocardia from 3 patients who underwent radiosurgery and died for various reasons 3 months to 9 months after radiotherapy. In Case 1 (death 3 months after radiotherapy) we observed a sharp transition between relatively intact and irradiated regions. In the myolytic foci, only scattered cardiomyocytes were left and the area was infiltrated by immune cells. Using immunohistochemistry we detected numerous inflammatory cells including CD68+/CD11c+ macrophages, CD4+ and CD8+ T-lymphocytes and some scattered CD20+ B-lymphocytes. Mast cells were diminished in contrast to viable myocardium. In Case 2 and Case 3 (death 6 and 9 months after radiotherapy, respectively) we found mostly fibrosis, infiltration by adipose tissue and foci of calcification. Inflammatory infiltrates were less pronounced. Our observations are in accordance with animal experimental studies and confirm a progress from myolysis to fibrosis. In addition, we demonstrate a role of pro-inflammatory macrophages in the earlier stages of myocardial remodeling after stereotactic radioablation for ventricular tachycardia.

Citing Articles

Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review.

Gupta A, Sattar Z, Chaaban N, Ranka S, Carlson C, Sami F Europace. 2024; 27(1).

PMID: 39716963 PMC: 11780863. DOI: 10.1093/europace/euae305.


Precision requirements in stereotactic arrhythmia radioablation for ventricular tachycardia.

Fast M, Lydiard S, Boda-Heggemann J, Tanadini-Lang S, Muren L, Clark C Phys Imaging Radiat Oncol. 2023; 28:100508.

PMID: 38026083 PMC: 10679852. DOI: 10.1016/j.phro.2023.100508.


Stereotactic Arrhythmia Radioablation (STAR): A Multidisciplinary Narrative Minireview of Preclinical Studies.

Galietta E, Strolin S, Bisello S, Cellini F, Lovato L, Ravegnini G In Vivo. 2023; 37(3):963-971.

PMID: 37103087 PMC: 10188005. DOI: 10.21873/invivo.13170.

References
1.
Refaat M, Ballout J, Zakka P, Hotait M, Al Feghali K, Gheida I . Swine Atrioventricular Node Ablation Using Stereotactic Radiosurgery: Methods and In Vivo Feasibility Investigation for Catheter-Free Ablation of Cardiac Arrhythmias. J Am Heart Assoc. 2017; 6(11). PMC: 5721791. DOI: 10.1161/JAHA.117.007193. View

2.
Lehmann H, Graeff C, Simoniello P, Constantinescu A, Takami M, Lugenbiel P . Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams. Sci Rep. 2016; 6:38895. PMC: 5171237. DOI: 10.1038/srep38895. View

3.
Rapp F, Simoniello P, Wiedemann J, Bahrami K, Grunebaum V, Ktitareva S . Biological Cardiac Tissue Effects of High-Energy Heavy Ions - Investigation for Myocardial Ablation. Sci Rep. 2019; 9(1):5000. PMC: 6428839. DOI: 10.1038/s41598-019-41314-x. View

4.
Jumeau R, Ozsahin M, Schwitter J, Elicin O, Reichlin T, Roten L . Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions. Front Cardiovasc Med. 2020; 7:108. PMC: 7329991. DOI: 10.3389/fcvm.2020.00108. View

5.
Cha M, Seo J, Kim H, Kim M, Yoon H, Jo S . Early Changes in Rat Heart After High-Dose Irradiation: Implications for Antiarrhythmic Effects of Cardiac Radioablation. J Am Heart Assoc. 2021; 10(6):e019072. PMC: 8174197. DOI: 10.1161/JAHA.120.019072. View